Form 8-K Erasca, Inc. For: Aug 12
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/23/2026
- Wall St futures ease as Big Tech results revive AI spending worries; oil jumps
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- Dollar hits fresh 40-year high versus yen, edges down against euro
- Oil prices rise for a fifth day as US-Iran hostilities threaten supply routes
Erasca Inc (ERAS) PT Lowered to $3 at Goldman Sachs
August 13, 2024 1:52 PM EDTGoldman Sachs analyst Chris Shibutani lowered the price target on Erasca Inc (NASDAQ: ERAS) to $3.00 (from $4.00) while maintaining a Buy rating.
The analyst comments "Post the company's prior announcement in May of a strategic reset with subsequent financings, the company's 2Q24 operational and program updates (see... More
Erasca Inc (ERAS) PT Raised to $6 at H.C. Wainwright
August 13, 2024 6:11 AM EDTH.C. Wainwright analyst Andres Y. Maldonado raised the price target on Erasca Inc (NASDAQ: ERAS) to $6.00 (from $5.00) while maintaining a Buy rating.
The analyst comments "What to expect from the newly initiated SEACRAFT-2 study. Erasca recently announced the initiation of the global SEACRAFT-2 Phase 3 trial to evaluate the pan-RAF inhibitor naporafenib in combination with the MEK inhibitor trametinib for patients with NRAS-mutant melanoma. Our positive outlook on this program is... More
